Skip to main content
SpringerLink
Log in

Management of Secondary and Tertiary Hyperparathyroidism

  • Chapter
  • First Online:
Book cover Endocrine Surgery

Part of the book series: Springer Specialist Surgery Series ((SPECIALIST))

  • 1736 Accesses

Secondary hyperparathyroidism (sHPT) is a condition that occurs when external factors stimulate the parathyroid glands to increase the secretion of parathyroid hormone (PTH), and develop mostly hyperplasia and/or adenomas of the parathyroid.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Silver J. Molecular mechanism of secondary hyperparathyroidism. Nephrol Dial Transplant. 2000;15(Suppl 5):S2–S7.

    Article  Google Scholar 

  2. Drücke TB. The pathogenesis of parathyroid gland hyperplasia in chronic renal failure. Kidney Int. 1995;48:259–72.

    Article  Google Scholar 

  3. Davies DR, Dent CE, Watson L. Tertiary hyperparathyroidism. BMJ. 1968;2:395–9.

    Article  Google Scholar 

  4. Delmez JA, Slatopolsky E. Hyperphosphatemia: its consequences and treatment in patients with chronic renal disease. Am J Kidney Dis. 1992;19:303–17.

    PubMed  CAS  Google Scholar 

  5. Llach F, Massry SG. On the mechanism of secondary hyperparathyroidism in moderate renal insufficiency. J Clin Endocrinol Metab. 1985;61:601–6.

    Article  PubMed  CAS  Google Scholar 

  6. Almaden Y, Hernandez A, Torregrosa V, et al. High phosphate level directly stimulates parathyroid hormone secretion and synthesis by human parathyroid tissue in vitro. J Am Soc Nephrol. 1998;9:1845–52.

    PubMed  CAS  Google Scholar 

  7. Cozzolino M, Lu Y, Finch J, Slatopolsky E, et al. p21WAFa and TGF-alpha mediate parathyroid growth arrest by vitamin D and high calcium. Kidney Int. 2001;60:2109–17.

    Article  PubMed  CAS  Google Scholar 

  8. Rosenblatt M, Kronenberg H, PottsJ. Parathyroid hormone. Physiology, chemistry, biosynthesis, secretion, metabolism, and mode of action. In: Defroot LJ, editors. Endocrinology, 2nd ed. Philadelphia: WB Saunders, 1989. 848.

    Google Scholar 

  9. Malberti F, Corradi B, Pagliari B, et al. The igmoidal parathyroid hormone-ionized calcium curve and the set point of calcium in hemodialysis and continuous ambulatory peritoneal dialysis. Perit Dial Int. 1993;13:S476–9.

    PubMed  Google Scholar 

  10. Fukagawa M, Kazama JJ. With or without the kidney: the role of FGF23 in CKD. Nephrol Dial Transplant. 2005;20:1295–8.

    Article  PubMed  CAS  Google Scholar 

  11. Tokumoto M, Taniguchi M, Matsuo D, et al. Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: vitamin d receptor, calcium sensing receptor, and cell cycle regulating factors. Ther Apher Dial. 2005;9:S27–34.

    Article  PubMed  CAS  Google Scholar 

  12. Rodriguez M, Nemeth E, Martin D. The calcium-sensing receptor: a key role in the pathogenesis of secondary hyperparathyroidism. Am J Physiol Renal Physiol. 2005;288:F253–64.

    Article  PubMed  CAS  Google Scholar 

  13. Stein MS, Packham DK, Ebeling PR, et al. Prevalence and risk in dialysis patients. Am J Kidney Dis. 1996;28:515–22.

    Article  PubMed  CAS  Google Scholar 

  14. Pletka PG, Strom TB, Hampers CL, et al. Secondary hperparathyrodism in human kidney transplant recipients. Nephron. 1976;17:371–381.

    Article  PubMed  CAS  Google Scholar 

  15. Saha HH, Salmela KT, Ahonen PJ, et al. Sequential changes in vitamin D and calcium metabolism after successful renal transplantation. Scand J Urol Nephrol. 1994;28:21–7.

    Article  PubMed  CAS  Google Scholar 

  16. Christensen MS, Nielsen HE. The clinical significance of hyperparathyroidism after renal transplantation. Scand J Urol Nephrol. 1977;(Suppl 42):130–3.

    Google Scholar 

  17. Malluche HH, Faugere M-C. Atlas of Mineralized Bone Histology. Basel, Switzerland: Karger; 1986;17–24.

    Google Scholar 

  18. Malluche HH. Aluminium and bone disease m chronic renal failure. Nephrol Dial Transplant. 2002;17(Suppl 2):21–4.

    PubMed  CAS  Google Scholar 

  19. Sherrard DJ. The role of aluminum in renal osteodystrophy. Mayo Clin Proc. 1993;68:510–1.

    PubMed  CAS  Google Scholar 

  20. Chan ED, Morales DV, Welsh CH, et al. Calcium deposition with or without bone formation in the lung. Am J Respir Crit Care Med. 2002;165:1654–69.

    Article  PubMed  Google Scholar 

  21. Strozecki P, Adamowicz A, Nartowicz E, et al. Parathormon, calcium, phosphorus, and left ventricular structure and function in normotensive hemodialysis patients. Ren Fail. 2001;23:115–26.

    Article  PubMed  CAS  Google Scholar 

  22. Hara S, Ubara Y, Arizono K, et al. Relation between parathyroid hormone and cardiac function in longterm hemodialysis patients. Miner Electrolyte Metab. 1995;21: 72–6.

    PubMed  CAS  Google Scholar 

  23. Vattikuti R, Towler DA. Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab. 2004;286:E686–96.

    Article  PubMed  CAS  Google Scholar 

  24. Guerin AP, London GM, Marchais SJ, et al. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant. 2000;15:1014–21.

    Article  PubMed  CAS  Google Scholar 

  25. Foley RN. Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure. Semin Dial. 2003;16:111–17.

    Article  PubMed  Google Scholar 

  26. Nasri H, Baradaran A, Naderi AS. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis. Acta Med Austriaca. 2004;31:67–72.

    PubMed  Google Scholar 

  27. Ketteler M, Bongartx P, Westenfeld R, et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet. 2003;361:827–33.

    Article  PubMed  CAS  Google Scholar 

  28. Alfrey AC. The role of abnormal phosphorus metabolism in the progression of chronic kidney disease and metastatic calcification. Kidney Int. 2004;90(Suppl):S13–7.

    Article  CAS  Google Scholar 

  29. Lingam RK, Teh J, Sharma A, Friedman E. Metastatic pulmonary calcification in renal failure: a new HRCT pattern. Brit J Radiol. 2002;75:74–7.

    PubMed  CAS  Google Scholar 

  30. Hiroshige K, Kabashima N, Takasugi M, et al. Optimal dialysis improves uremic pruritus. Am J Kidney Dis. 1995;25:413–9.

    Article  PubMed  CAS  Google Scholar 

  31. Demeure MJ, McGee DC, Wilkes W, et al. Results of surgical treatment for hyperparathyroidism associated with renal disease. AM J Surg. 1990;160:337–40.

    Article  PubMed  CAS  Google Scholar 

  32. Duh QY, Lim RC, Clark OH. Calciphylaxis in secondary hyperparathyroidism. Diagnosis and parathyroidectomy. Arch Surg. 1991;126:1213–8; discussion 1218–9.

    PubMed  CAS  Google Scholar 

  33. Schaffer C, Heiss A, Schwarz A, et al. The serum protein a2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest. 2003;112:357–66.

    Google Scholar 

  34. Toorians AW, Janssen E, Laan E, et al. Chronic renal failure and sexual functioning: clinical status versus objectively assessed sexual response. Nephrol Dial Transplant. 1997;12:2654–63.

    Article  PubMed  CAS  Google Scholar 

  35. Eknoyan G, Levm A, Levin NW, for the National Kidney Foundation. Bone metabolism and disease m chronic kidney disease. Am J Kidney Dis. 2003;42:1–201.

    Article  Google Scholar 

  36. Massry SG. Pathogenesis of the anemia of uremia: Role of secondary hyperparathyroidism. Kidney Int. 1983;16(Suppl):S204–7.

    CAS  Google Scholar 

  37. Rao DS, Shih MS, Mohini R. Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. N Engl J Med. 1993;328:171–5.

    Article  PubMed  CAS  Google Scholar 

  38. Young EW, Albert JM, Satayathum S, et al. Predictors and consequence of altered mineral metabolism: the dialysis outcomes prac pattern study. Kidney Int. 2005;67:1179–87.

    Article  PubMed  CAS  Google Scholar 

  39. Onoda N, Kashiwagi T, Nakamura T, et al. Parathyroid interventions for secondary hyperparathyroidism in hemodialyzed patients. Ther Apher Dial. 2005;9:S11–5.

    Article  PubMed  Google Scholar 

  40. Indriason OS, Quarles LD. Comparison of treatments for mild secondary hyperparathyroidism in hemodialysis patients. Kidney Int. 2000;57:282–92.

    Article  Google Scholar 

  41. Weber CK, Friedrich JM, Merkle E, et al. Reversible metastatic pulmonary calcification in a patient with multiple myeloma. Ann Hematol. 1996;72:329–32.

    Article  PubMed  CAS  Google Scholar 

  42. Roe SM, Graham LD, Brock WB, et al. Calciphylaxis: early recognition and management. Am Surg. 1994;60:81–6.

    PubMed  CAS  Google Scholar 

  43. Park CW, Oh YS, Shin YS, et al. Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis. 1999;33:73–81.

    Article  PubMed  CAS  Google Scholar 

  44. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42:S1–202.

    Google Scholar 

  45. Tominaga Y. Uremic calciphylaxis syndrome: calcified uremic artheriolopathy. Int Med. 2001;40:1174–5.

    Article  CAS  Google Scholar 

  46. Block GA, Hulbert-Shearon TE, Levin NW, et al. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J kidney Dis. 1998;31:607–17.

    Article  PubMed  CAS  Google Scholar 

  47. Medical Expert Group (Chair: Cannata-Andia JB, and Drueke TB). Clinical algorithms on renal osteodystrophy. Nephrol Dial Transplant. 2000;15(Suppl 5):39–57.

    Google Scholar 

  48. Tominaga Y, Matsuoka S, Sato T. Surgical indications and procedures of parathyroidectomy in patients with chronic kidney disease. Ther Apher Dial. 2005;9:44–7.

    Article  PubMed  Google Scholar 

  49. Tanaka Y, Tominaga Y, Funahashi H, et al. Preoperative localization studies in secondary hyperplasia. Acta Chir Austriaca Suppl. 1996;124:14–6.

    Google Scholar 

  50. Pasieka JL, Parsons LL A prospective surgical outcome study assessing the impact of parathyroidectomy on symptoms in patients with secondary and tertiary hyperparathyroidism. Surgery. 2000;128:531–9

    Article  PubMed  CAS  Google Scholar 

  51. Fletcher S, Kanagasundaram NS, Rayner HC, et al. Assessment of ultrasound guided percutaneous ethanol injection and parathyroidectomy in patients with tertiary hyperparathyroidism. Nephrol Dial Transplant. 1998;13:3111–7

    Article  PubMed  CAS  Google Scholar 

  52. Decker PA, Cohen EP, Doffek KM, et al. Subtotal parathyroidectomy in renal failure: still needed after all these years. World J Surg. 2001;25:708–12

    Article  PubMed  CAS  Google Scholar 

  53. D’Alessandro AM, Melzer JS, Pirsh KD, et al. Tertiary hyperparathyroidism after renal transplantation: operative indications. Surgery. 1989;106:1049–55.

    PubMed  Google Scholar 

  54. Kinnaert P, Nagy N, Decister-Gervy C, et al. Peresistent hyperparathyroidism requiring surgical treatment after kidnely transplantation World J Surg. 2000;24:1391–5.

    CAS  Google Scholar 

  55. Kerby KD, Rue KW, Blair H, et al. Operative treatment of tertiary hyperparathyroidism A single-center experience. Ann surg. 1998;227(6):878–886.

    Article  PubMed  CAS  Google Scholar 

  56. Geis WP, Popovitzer MM, Corman JL, et al. The diagnosis and treatment of hyperparathyrodism after renal transplantation. Surg Gyecol Obster. 1973;137:997–1010.

    CAS  Google Scholar 

  57. David DS, Sakai S, Brennan BL, et al. Hypecalcemia after renal transplantation. N Eng J Med. 1973;289:398.

    Article  CAS  Google Scholar 

  58. Tominaga Y, Katayama A, Sato T, et al. Re-operation is frequently required when parathyroid glands remain after initial parathyroidectomy for advanced secondary hyperparathyroidism in uraemic patients. Nephrol Dial Transplant. 2003;18(Suppl 3):65–70.

    Google Scholar 

  59. Takagi H, Tominaga Y, Uchida K, et al. Subtotal versus total parathyroidectomy with forearm autograft for secondary hyperparathyroidism in chronic renal failure. Ann Surg. 1984;200(1):18–23.

    Article  PubMed  CAS  Google Scholar 

  60. Neonakis E, Wheeler MH, Krishnan H, et al. Results of surgical treatment of renal hyperparathyroidism. Arch Surg. 1995;130:643–8.

    PubMed  CAS  Google Scholar 

  61. Richards ML, Wormuth J, Bingener J, et al. Parathyroidectomy in secondary hyperparathyroidism: Is there an optimal operative management? Surgery. 2006;139:174–80.

    Article  PubMed  Google Scholar 

  62. Stracke S, Jehle PM, Sturm D, et al. Clinical course after total parathyroidectomy without autotransplantation in patients with end-stage renal failure. Am J Kidney Dis. 1999;33:304–11.

    Article  PubMed  CAS  Google Scholar 

  63. Al-Sobhi S, Clark OH. Parathyroid hyperplasia: parathyroidectomy. In Clark OH, Duh QY, editors. Textbook of endocrine surgery, 2nd edition. Philadelphia: WB Saunders, 2005.

    Google Scholar 

  64. Hampl H, Steinmuller T, Stabell U, et al. Recurrent hyperparathyroidism after total parathyroidectomy and autotransplantation in patients with long-term hemodialysis. Miner Electrolyte Metab. 1991;17:256–60.

    PubMed  CAS  Google Scholar 

  65. Tominaga Y. Surgical management of secondary hyperparathyroidism in uremia. Am J Med Sci. 1999;317:390–7.

    Article  PubMed  CAS  Google Scholar 

  66. Saxe AW, Brennan MF. Reoperative parathyroid surgery for primary hyperparathyroidism caused by multiple-gland disease: total parathyroidectomy and autotransplantation with cryopreserved tissue. Surgery. 1982;91:616–21.

    PubMed  CAS  Google Scholar 

  67. Chou FF, Lee CH, Chen JB, et al. Intraoperative parathyroid hormone measurement in patients with secondary hyperparathyroidectomy. Arch Surg. 2002;137:341–4.

    Article  PubMed  CAS  Google Scholar 

  68. Kebebew E, Duh QY, Clark OH. Tertiary hyperparathyroidism Histologic patterns of disease and results of parathyroidectomy Arch Surg. 2004;139:974–7

    Google Scholar 

  69. Triponez F, Kebebew E, Dossh D, et al. Less-than-subtotal parathyroidectomy increases the risk of persistent/recurrent hyperparathyroidism after parathyroidectomy in tertiary hyperparathyroidism after renal transplantation Surgery. 2006;140:990–9.

    Google Scholar 

  70. Kilgo MS, Pirsch JD, Warner TF, et al. Tertiary hyperparathyroidism after renal transplantation: surgical strategy. Surgery. 1998;124:677–84.

    Article  PubMed  CAS  Google Scholar 

  71. Thanasoulis L, Bingerner J, Sirinek K, et al. A successful application of the intraoperative parathyroid hormone assay in tertiary hyperparathyroidism Am Surg. 2007;73:281–3.

    Google Scholar 

  72. Nichol PF, Mack E, Bianco J, et al. Radioguided parathyroidectomy in patients with secondary and tertiary hyperparathyroidism. Surgery. 2003;134:713–9.

    Article  PubMed  Google Scholar 

  73. Walgenbach S, Junginger T. Intraoperative parathyroid hormone monitoring in neck exploration for renal hyperparathyroidism? Chirurg. 2002;73: 211–6.

    Article  PubMed  CAS  Google Scholar 

  74. Clary BM, Garner SC, Leight GS Jr. Intraoperative parathyroid hormone monitoring during parathyroidectomy for secondary hyperparathyroidism. Surgery. 1997;122:1034–8.

    Article  PubMed  CAS  Google Scholar 

  75. Yamashita H, Noguchi S, Futata T, et al. Usefulness of quick intraoperative measurements of intact parathyroid hormone in the surgical management of hyperparathyroidism. Biomed Pharmacother. 2000;54(Suppl 1): 108–11.

    Article  Google Scholar 

  76. Tanaka M, Itoh K, Matsushita K, et al. Efficacy of percutaneous ethanol injection therapy for secondary hyperparathyroidism in patients on hemodialysis as evaluated by parathyroid hormone levels according to K/DOQI guidelines. Ther Apher Dial 2005;9:48–52.

    Article  PubMed  Google Scholar 

  77. Shiizaki K, Negi S, Hatamura I, et al. Biochemical and cellular effects of direct maxacalcitol injection into parathyroid gland in uremic rats. J Am Soc Nephrol. 2005;16:97–108.

    Article  PubMed  CAS  Google Scholar 

  78. Cattan P, Halimi B, Aidan K, et al. Reoperation for secondary uremic hyperparathyroidism: are technical difficulties influenced by initial surgical procedure? Surgery. 2000;127(5):620–25.

    Article  Google Scholar 

  79. Tominaga Y. Surgical treatment of secondary hyperparathyroidism due to chronic kidney disease. Ups J Med Sci. 2006;111:277–92.

    Article  PubMed  Google Scholar 

  80. Kestenbaum B, Andress DL, Schwartz SM, et al. Survival following parathyroidectomy among United States dialysis patients. Kidney Int. 2004;66:2010–6.

    Article  PubMed  Google Scholar 

  81. Gagne ER, Urena P, Leite-Silva S, et al. Short- and long-term efficacy of total parathyroidectomy with immediate autografting compared with subtotal parathyroidectomy in hemodialysis patients. J Am Soc Nephrol. 1992;3:1008–17.

    PubMed  CAS  Google Scholar 

  82. Coen G, Calabria S, Bellinghieri G, et al. Parathyroidectomy in chronic renal failure: short- and long-term results on parathyroid function, blood pressure and anemia. Nephron. 2001;88:149–55.

    Article  PubMed  CAS  Google Scholar 

  83. Takagi H, Tominaga Y, Tanaka Y, et al. Total parathyroidectomy with forearm autograft for secondary hyperparathyroidism in chronic renal failure. Ann Surg. 1988;208:639–44.

    Article  PubMed  CAS  Google Scholar 

  84. Kinnaert P, Salmon I, Deoster-Gervy C, et al. Long-term results of subcutaneous parathyroid grafts in uremic patients. Arch Surg. 2000;135:186–90.

    Article  PubMed  CAS  Google Scholar 

  85. Henry JF, Denizot A, Audiffret J, et al. Results of reoperations for persistent or recurrent secondary hyperparathyroidism in hemodialysis patients. World J Surg. 1990;14:303–6.

    Article  PubMed  CAS  Google Scholar 

  86. Kinnaert P, Nagy N, Decoster-Gervy C, et al. Persistent hyperparathyroidism requiring surgical treatment after kidney transplantation. World J Surg. 2000;24:1391–5.

    Article  PubMed  CAS  Google Scholar 

  87. De Francisco AL, Amado JA, Casanova D, et al. Recurrence of hyperparathyroidism after total parathyroidectomy with autotransplantation: a new technique to localize source of hormone excess. Nephron. 1991;58:306–9.

    Article  PubMed  Google Scholar 

  88. Yajima A, Ogawa Y, Takahashi HE, et al. Changes of bone remodeling immediately after parathyroidectomy for secondary hyperparathyroidism. Am J Kidney dis. 2003;42:729–38.

    Article  PubMed  Google Scholar 

  89. Yano S, Sugimoto T, Tsukamoto T, et al. Effect of parathyroidectomy on bone mineral density in hemodialysis patients with secondary hyperparathyroidism: possible usefulness of preoperative determination of parathyroid hormone level for prediction of bone regain. Horm Metab Res. 2003;35:259–64.

    Article  PubMed  CAS  Google Scholar 

  90. Chou FF, Chen JB, Lee Ch, et al. Parathyroidectomy can improved bone mineral density in patients with symptomatic secondary hyperparathyroidism in dialysis patients: recommendation for a change in management. Am J Kidney Dis. 2000;35:1226–37.

    Article  Google Scholar 

  91. Goldsmith DJ, Covic AA, Venning MC, et al. Blood pressure reduction after parathyroidectomy for secondary hyperparathyroidism: further evidence implicating calcium homeostasis in blood pressure regulation. Am J Kidney Dis. 1996;27:819–25.

    Article  PubMed  CAS  Google Scholar 

  92. Zingraff J, Drueke T, Marie P, et al. Anemia and secondary hyperparathyroidism Arch Interm Med. 1978;138(11):1650–2

    CAS  Google Scholar 

  93. Brancaccio D, Cozzolino M, Gallieni M. Hyperparathyroidism and anemia in uremic subjects : a combined therapeutic approach. J Am Soc Nephrol. 2004;15:S21–4

    Article  PubMed  Google Scholar 

  94. Ifudu O, Matthew JJ, Macey LJ, Hong JS, Sumrani N, Sommer BG, Friedman EA. Parathyroidectomy does not correct hypertension in patients on maintenance hemodialysis. Am J Nephrol. 1998;18:28–34.

    Article  PubMed  CAS  Google Scholar 

  95. Parfitt AM. Soft-tissue calcification in uremia. Arch Intern Med. 1969;124:544–56.

    Article  PubMed  CAS  Google Scholar 

  96. Bleyer AJ, Burkart J, Piazza M, et al. Changes in cardiovascular calcification after parathyroidectomy in patients with ESRD. Am J Kidney Dis. 2005;46:464–9.

    Article  PubMed  Google Scholar 

  97. De Francisco AM, Ellis HA, Owen JP, et al. Parathyroidectomy in chronic renal failure. Q J Med. 1985;55:289–315.

    PubMed  Google Scholar 

  98. Goto N, Tominaga Y, Matsuoka S, et al. Cardiovascular complications caused advanced secondary hyperparathyroidism in chronic dialysis patients; special focus on dilated cardiomyopathy. Clin Exp Nephrol. 2005;9:138–41.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, National Yang-Ming University, Taipei Veterans General Hospital, Taipei, Taiwan

    Jui-Yu Chen MD & Ling-Ming Tseng MD

  2. Department of Surgery, National Yang-Ming University, Taipei, Taiwan

    Chen-Hsen Lee MD

Authors
  1. Jui-Yu Chen MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ling-Ming Tseng MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chen-Hsen Lee MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. St Thomas Hospital, Lambeth Palace Road, London SE1 7EH, United Kingdom

    Johnathan Hubbard

  2. Coll Physicians & Surgeons Columbia, Fort Washington Avenue 161, New York, 10032, U.S.A.

    William B. Inabnet

  3. Queen Mary Hospital, University of Hong Kong Medical Centre, Pokfulam, Hong Kong, China, People's Republic

    Chung-Yau Lo

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag London Limited

About this chapter

Cite this chapter

Chen, JY., Tseng, LM., Lee, CH. (2009). Management of Secondary and Tertiary Hyperparathyroidism. In: Hubbard, J., Inabnet, W., Lo, CY. (eds) Endocrine Surgery. Springer Specialist Surgery Series. Springer, London. https://doi.org/10.1007/978-1-84628-881-4_22

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-881-4_22

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-880-7

  • Online ISBN: 978-1-84628-881-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation